MedicareNCDBstage IIB/C melanomaPembrolizumabstage IIB/IIC melanomaFDAadjuvant immunotherapy
…When limiting to post-approval among patients with IIC disease, Medicare and uninsured compared to privately insured were less likely to…
1articles mentioning funders
2funder mentions
1distinct funders extracted
0%of mentions human-reviewed
Active filtersEntity: NCDB ×
NCDB
This funder is selected. Its supporting articles are shown below.